Eli Lilly Announces Board Changes and Officer Compensation Details
Ticker: LLY · Form: 8-K · Filed: Jun 5, 2024 · CIK: 59478
| Field | Detail |
|---|---|
| Company | Eli Lilly & Co (LLY) |
| Form Type | 8-K |
| Filed Date | Jun 5, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, board-of-directors, officer-compensation
Related Tickers: LLY
TL;DR
Lilly's board is shuffling, with new directors coming on board and exec pay details emerging.
AI Summary
Eli Lilly and Company (LLY) filed an 8-K on June 5, 2024, reporting on the departure of director Michael L. Smith and the election of new directors, including Ann M. D. Smith and David A. Ricks. The filing also details compensatory arrangements for certain officers and includes financial statements and exhibits. No specific dollar amounts related to compensation changes were detailed in the provided text.
Why It Matters
Changes in a company's board of directors can signal shifts in strategic direction or governance, while details on officer compensation provide insight into executive incentives.
Risk Assessment
Risk Level: low — The filing primarily concerns routine corporate governance and executive compensation disclosures, with no immediate financial risks indicated.
Key Players & Entities
- Eli Lilly and Company (company) — Filer
- Michael L. Smith (person) — Departing Director
- Ann M. D. Smith (person) — Elected Director
- David A. Ricks (person) — Elected Director
- 0000059478-24-000146 (document_id) — Accession Number
FAQ
Who has departed from Eli Lilly's board of directors?
Michael L. Smith has departed from the board of directors.
Who has been elected to Eli Lilly's board of directors?
Ann M. D. Smith and David A. Ricks have been elected to the board of directors.
What type of information is included in the filing besides board changes?
The filing also includes details on compensatory arrangements of certain officers and financial statements and exhibits.
When was this 8-K filing submitted?
This 8-K filing was submitted on June 5, 2024.
What is the SIC code for Eli Lilly and Company?
The Standard Industrial Classification (SIC) code for Eli Lilly and Company is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 593 words · 2 min read · ~2 pages · Grade level 9.5 · Accepted 2024-06-05 07:48:12
Filing Documents
- lly-20240602.htm (8-K) — 49KB
- ashkenazi_060524.htm (EX-99.1) — 17KB
- image_0.jpg (GRAPHIC) — 25KB
- image_1.jpg (GRAPHIC) — 86KB
- 0000059478-24-000146.txt ( ) — 442KB
- lly-20240602.xsd (EX-101.SCH) — 5KB
- lly-20240602_def.xml (EX-101.DEF) — 19KB
- lly-20240602_lab.xml (EX-101.LAB) — 37KB
- lly-20240602_pre.xml (EX-101.PRE) — 20KB
- lly-20240602_htm.xml (XML) — 10KB
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release of Eli Lilly and Company, dated June 5, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. ELI LILLY AND COMPANY (Registrant) By: /s/ Anat Hakim Name: Anat Hakim Title: Executive Vice President, General Counsel and Secretary Date: June 5, 2024